These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10590272)

  • 1. beta-lactams: variations on a chemical theme, with some surprising biological results.
    Hamilton-Miller JM
    J Antimicrob Chemother; 1999 Dec; 44(6):729-34. PubMed ID: 10590272
    [No Abstract]   [Full Text] [Related]  

  • 2. Organic carbamates in drug design and medicinal chemistry.
    Ghosh AK; Brindisi M
    J Med Chem; 2015 Apr; 58(7):2895-940. PubMed ID: 25565044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based organic synthesis of drug prototypes: a personal odyssey.
    Hanessian S
    ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524
    [No Abstract]   [Full Text] [Related]  

  • 4. beta-Lactam derivatives as inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Guse I; Haché B; Naud J; O'Meara JA; Plante R; Déziel R
    J Med Chem; 1998 Jul; 41(15):2882-91. PubMed ID: 9667976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactam compounds as apparently uncompetitive inhibitors of HIV-1 protease.
    Sperka T; Pitlik J; Bagossi P; Tözsér J
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3086-90. PubMed ID: 15893929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity.
    Lasheen DS; Ismail MA; Abou El Ella DA; Ismail NS; Eid S; Vleck S; Glenn JS; Watts AG; Abouzid KA
    Bioorg Med Chem; 2013 May; 21(10):2742-55. PubMed ID: 23583031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent beta-lactam inhibitors of human cytomegalovirus protease.
    Yoakim C; Ogilvie WW; Cameron DR; Chabot C; Grand-Maître C; Guse I; Haché B; Kawai S; Naud J; O'Meara JA; Plante R; Déziel R
    Antivir Chem Chemother; 1998 Sep; 9(5):379-87. PubMed ID: 9875391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Novel inhibitors against the bacterial signal peptidase I].
    Liao GJ; He Y; Xie JP
    Yao Xue Xue Bao; 2012 Dec; 47(12):1561-6. PubMed ID: 23460958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardamine sp. - A review on its chemical and biological profiles.
    Montaut S; Bleeker RS
    Chem Biodivers; 2011 Jun; 8(6):955-75. PubMed ID: 21674775
    [No Abstract]   [Full Text] [Related]  

  • 10. From natural products to bioorganic chemistry. What's next?
    Ellestad GA
    J Med Chem; 2006 Nov; 49(23):6627-34. PubMed ID: 17154489
    [No Abstract]   [Full Text] [Related]  

  • 11. Design of beta-lactams with mechanism based nonantibacterial activities.
    Veinberg G; Vorona M; Shestakova I; Kanepe I; Lukevics E
    Curr Med Chem; 2003 Sep; 10(17):1741-57. PubMed ID: 12871119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyphomycetes as organisms producing cyclodepsipeptides].
    Bibikova MV; Puzhevskaia TO; Katlinskiĭ AV
    Antibiot Khimioter; 2010; 55(3-4):35-44. PubMed ID: 20695207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudo-symmetrical difluoroketones. Highly potent and specific inhibitors of HIV-1 protease.
    Sham HL; Betebenner DA; Wideburg N; Saldivar AC; Kohlbrenner WE; Craig-Kennard A; Vasavanonda S; Kempf DJ; Clement JJ; Erickson JE
    FEBS Lett; 1993 Aug; 329(1-2):144-6. PubMed ID: 8354389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between inhibitors of eukaryotic and prokaryotic serine proteases.
    Konaklieva MI; Plotkin BJ
    Mini Rev Med Chem; 2004 Sep; 4(7):721-39. PubMed ID: 15379640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolytic stability versus ring size in lactams: implications for the development of lactam antibiotics and other serine protease inhibitors.
    Imming P; Klar B; Dix D
    J Med Chem; 2000 Nov; 43(22):4328-31. PubMed ID: 11063627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors.
    Takaya D; Yamashita A; Kamijo K; Gomi J; Ito M; Maekawa S; Enomoto N; Sakamoto N; Watanabe Y; Arai R; Umeyama H; Honma T; Matsumoto T; Yokoyama S
    Bioorg Med Chem; 2011 Nov; 19(22):6892-905. PubMed ID: 21992802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward the Synthesis of Fluorinated Analogues of HCV NS3/4A Serine Protease Inhibitors Using Methyl α-Amino-β-fluoro-β-vinylcyclopropanecarboxylate as Key Intermediate.
    Milanole G; Andriessen F; Lemonnier G; Sebban M; Coadou G; Couve-Bonnaire S; Bonfanti JF; Jubault P; Pannecoucke X
    Org Lett; 2015 Jun; 17(12):2968-71. PubMed ID: 26053226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease.
    Alexandre FR; Brandt G; Caillet C; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Parsy C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3984-91. PubMed ID: 26231161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recently reported biological activities of pyrazole compounds.
    Faria JV; Vegi PF; Miguita AGC; Dos Santos MS; Boechat N; Bernardino AMR
    Bioorg Med Chem; 2017 Nov; 25(21):5891-5903. PubMed ID: 28988624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.